Nami McCarty

3.2k total citations
23 papers, 526 citations indexed

About

Nami McCarty is a scholar working on Molecular Biology, Epidemiology and Immunology. According to data from OpenAlex, Nami McCarty has authored 23 papers receiving a total of 526 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Epidemiology and 7 papers in Immunology. Recurrent topics in Nami McCarty's work include Autophagy in Disease and Therapy (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Nami McCarty is often cited by papers focused on Autophagy in Disease and Therapy (7 papers), Lymphoma Diagnosis and Treatment (6 papers) and Multiple Myeloma Research and Treatments (4 papers). Nami McCarty collaborates with scholars based in United States and South Korea. Nami McCarty's co-authors include Han Zhang, Zhen Chen, Han Zhang, Zheng Chen, Michael Wang, Larry W. Kwak, Hyun Joo Jung, L. Jeffrey Medeiros, Roberto N. Miranda and Zheng Chen and has published in prestigious journals such as Journal of Clinical Investigation, Blood and PLoS ONE.

In The Last Decade

Nami McCarty

23 papers receiving 524 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nami McCarty United States 15 287 172 113 107 96 23 526
Valeria Cambiaghi Italy 9 335 1.2× 168 1.0× 76 0.7× 126 1.2× 47 0.5× 10 520
Cristina Mirantes Spain 13 279 1.0× 168 1.0× 35 0.3× 142 1.3× 55 0.6× 17 595
Cecilia Kelly United States 2 651 2.3× 249 1.4× 82 0.7× 159 1.5× 154 1.6× 4 879
James J. Ignatz-Hoover United States 12 379 1.3× 273 1.6× 48 0.4× 251 2.3× 46 0.5× 25 749
Erica Riveiro‐Falkenbach Spain 10 362 1.3× 192 1.1× 105 0.9× 94 0.9× 65 0.7× 25 575
Bei Jin China 11 400 1.4× 122 0.7× 33 0.3× 69 0.6× 33 0.3× 15 578
Kedar Inamdar United States 15 393 1.4× 253 1.5× 49 0.4× 141 1.3× 276 2.9× 39 772
L. Dousset France 11 205 0.7× 344 2.0× 53 0.5× 108 1.0× 59 0.6× 34 618
Raymond J. Lim United States 7 317 1.1× 175 1.0× 31 0.3× 164 1.5× 39 0.4× 17 518
Jorg Michels Canada 8 280 1.0× 151 0.9× 29 0.3× 85 0.8× 47 0.5× 14 451

Countries citing papers authored by Nami McCarty

Since Specialization
Citations

This map shows the geographic impact of Nami McCarty's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nami McCarty with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nami McCarty more than expected).

Fields of papers citing papers by Nami McCarty

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nami McCarty. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nami McCarty. The network helps show where Nami McCarty may publish in the future.

Co-authorship network of co-authors of Nami McCarty

This figure shows the co-authorship network connecting the top 25 collaborators of Nami McCarty. A scholar is included among the top collaborators of Nami McCarty based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nami McCarty. Nami McCarty is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vu, Trung, et al.. (2024). TRIM44, a Novel Prognostic Marker, Supports the Survival of Proteasome-Resistant Multiple Myeloma Cells. Cells. 13(17). 1431–1431. 4 indexed citations
2.
Wang, Yuqin, et al.. (2024). TRIM44 enhances autophagy via SQSTM1 oligomerization in response to oxidative stress. Scientific Reports. 14(1). 18974–18974. 6 indexed citations
3.
Vu, Trung, et al.. (2023). Comprehensive Analysis of the Prognostic Significance of the TRIM Family in the Context of TP53 Mutations in Cancers. Cancers. 15(15). 3792–3792. 3 indexed citations
4.
McCarty, Nami, et al.. (2021). TRIM44 mediated p62 deubiquitination enhances DNA damage repair by increasing nuclear FLNA and 53BP1 expression. Oncogene. 40(32). 5116–5130. 21 indexed citations
5.
Chen, Zheng, et al.. (2021). TRIM44 links the UPS to SQSTM1/p62-dependent aggrephagy and removing misfolded proteins. Autophagy. 18(4). 783–798. 42 indexed citations
6.
Chen, Zheng, Xiaohong Bi, Brian C. Dawson, et al.. (2018). TRIM44 promotes quiescent multiple myeloma cell occupancy and survival in the osteoblastic niche via HIF-1α stabilization. Leukemia. 33(2). 469–486. 39 indexed citations
7.
Zhang, Han & Nami McCarty. (2017). CRISPR Editing in Biological and Biomedical Investigation. Journal of Cellular Biochemistry. 118(12). 4152–4162. 6 indexed citations
8.
Zhang, Han, Zheng Chen, Roberto N. Miranda, L. Jeffrey Medeiros, & Nami McCarty. (2016). TG2 and NF-κB Signaling Coordinates the Survival of Mantle Cell Lymphoma Cells via IL6-Mediated Autophagy. Cancer Research. 76(21). 6410–6423. 46 indexed citations
9.
Zhang, Han, Zheng Chen, Sattva S. Neelapu, Jorge Romaguera, & Nami McCarty. (2016). Hedgehog inhibitors selectively target cell migration and adhesion of mantle cell lymphoma in bone marrow microenvironment. Oncotarget. 7(12). 14350–14365. 24 indexed citations
10.
Zhang, Han & Nami McCarty. (2016). CRISPR‐Cas9 technology and its application in haematological disorders. British Journal of Haematology. 175(2). 208–225. 30 indexed citations
11.
12.
Chen, Zheng, Robert Z. Orlowski, Michael Wang, Larry W. Kwak, & Nami McCarty. (2014). Osteoblastic niche supports the growth of quiescent multiple myeloma cells. Blood. 123(14). 2204–2208. 59 indexed citations
13.
Chen, Zhen, Luis Fayad, Michael Wang, et al.. (2013). Nuclear Translocation of B-Cell-Specific Transcription Factor, BACH2, Modulates ROS Mediated Cytotoxic Responses in Mantle Cell Lymphoma. PLoS ONE. 8(8). e69126–e69126. 29 indexed citations
14.
Jung, Hyun Joo, Zhen Chen, & Nami McCarty. (2012). Synergistic anticancer effects of arsenic trioxide with bortezomib in mantle cell lymphoma. American Journal of Hematology. 87(12). 1057–1064. 19 indexed citations
15.
Jung, Hyun‐Joo, Zheng Chen, & Nami McCarty. (2012). Abstract 3364: Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma (MCL) via manipulation of tissue transglutaminase activities.. Cancer Research. 72(8_Supplement). 3364–3364. 1 indexed citations
16.
Jung, Hyun Joo, Zheng Chen, & Nami McCarty. (2011). Stem-like tumor cells confer drug resistant properties to mantle cell lymphoma. Leukemia & lymphoma. 52(6). 1066–1079. 17 indexed citations
17.
Jung, Hyun Joo, Luis Fayad, Michael Wang, et al.. (2011). Bortezomib-resistant nuclear factor κB expression in stem-like cells in mantle cell lymphoma. Experimental Hematology. 40(2). 107–118.e2. 16 indexed citations
18.
Chen, Zhen, Michael Wang, Luis Fayad, et al.. (2010). Prospective isolation of clonogenic mantle cell lymphoma-initiating cells. Stem Cell Research. 5(3). 212–225. 21 indexed citations
19.
Jung, Hyun Joo & Nami McCarty. (2010). Stem-Like Tumor Cells Confer Drug Resistant Properties to Mantle Cell Lymphoma. Blood. 116(21). 1840–1840. 1 indexed citations
20.
Panoutsakopoulou, Vily, Katharina M. Huster, Nami McCarty, et al.. (2004). Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. Journal of Clinical Investigation. 113(8). 1218–1224. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Valeria Cambiaghi Breakdown of academic impact, for papers by Cristina Mirantes Breakdown of academic impact, for papers by Cecilia Kelly Breakdown of academic impact, for papers by James J. Ignatz-Hoover Breakdown of academic impact, for papers by Erica Riveiro‐Falkenbach Breakdown of academic impact, for papers by Bei Jin Breakdown of academic impact, for papers by Kedar Inamdar Breakdown of academic impact, for papers by L. Dousset Breakdown of academic impact, for papers by Raymond J. Lim Breakdown of academic impact, for papers by Jorg Michels
Rankless by CCL
2026